INS and Hypoglycemia: Smart nanocarrier-based drug delivery systems, such as glucose-responsive NPs synthesized from dextran, have demonstrated rapid and extended self-regulated insulin delivery, effectively reducing elevated blood glucose levels in mice and minimizing the risk of hypoglycemia [86].